Insiders · OCGN

Huma Qamar

Chief Medical Officer at Ocugen, Inc. (OCGN) since March 2024

Huma Qamar has filed 3 insider reports with the SEC since March 2024, as chief Medical Officer at Ocugen, Inc. (OCGN). The latest filing, on January 6, 2025, reports grant or award at Ocugen, Inc. (OCGN).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Huma Qamar is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Ocugen, Inc. logo
OCGN
Ocugen, Inc.
Chief Medical Officersince March 20241,643$0.7679Jan 6, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Huma Qamar with

Other insiders at the same companies

Questions about Huma Qamar

What is Huma Qamar's role at Ocugen, Inc.?
Huma Qamar reports to the SEC as chief Medical Officer at Ocugen, Inc. (OCGN), according to the latest filing on January 6, 2025.
How many shares does Huma Qamar own?
After the latest filing that states it, Huma Qamar directly owned 1,643 shares of Ocugen, Inc. (OCGN). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Huma Qamar bought or sold stock recently?
No open-market purchases or sales by Huma Qamar are on file. The filings report grant or award.
How do I get alerts when Huma Qamar files?
Follow Huma Qamar on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Huma Qamar (SEC CIK 0002015296). Totals count each trade once, skipping amendments whose original is on file, from Mar 20, 2024 on. View on SEC EDGAR · Get this as JSON